TheProfitWatch

TCRT - Alaunos Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.33 -0.25 (-7.51%) --- --- --- -0.02 (-0.6%) -0.17 (-5.04%) -0.1 (-3.14%) -0.1 (-3.14%)

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.63
Diluted EPS:
-0.63
Basic P/E:
-4.8889
Diluted P/E:
-4.8889
RSI(14) 1m:
0.0
VWAP:
3.08
RVol:

Events

Period Kind Movement Occurred At

Related News